Esperion Therapeutics, Inc. Rings the Opening Bell

Name: Esperion Therapeutics, Inc. Rings the Opening Bell
Start: 2024-04-01T13:15:00
End: 2024-04-01T13:45:00
Location: 4 Times Square, New York , NYUnited States

April 01, 2024 — 9:15 AM - 9:45 AM ET

Nasdaq MarketSite, 4 Times Square, , New York

About This Event

Esperion (Nasdaq: ESPR), a pharmaceutical company who recently announced the U.S. FDA approval of expanded indications for NEXLETOL^® (bempedoic acid) Tablet and NEXLIZET^®(bempedoic acid and ezetimibe) Tablet to include cardiovascular risk reduction and LDL cholesterol lowering in primary and secondary prevention patients, regardless of statin use, visits the Nasdaq MarketSite in Times Square.

In honor of these recent FDA approvals, Sheldon Koenig, President & CEO, rings the Opening Bell.

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.